Evidence map›Paper›PMID 32512878›Full record

ArticleGenes2020

Ultra-Deep DNA Methylation Analysis of X-Linked Genes:

Giulia De Riso, Mariella Cuomo, Teodolinda Di Risi, Rosa Della Monica, Michela Buonaiuto, Davide Costabile, Antonio Pisani, Sergio Cocozza, Lorenzo Chiariotti

Open access · goldAbstract read
In one paragraph

Article in Genes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Dysregulated DNA methylation in the pathogenesis of Fabry disease.Molecular genetics and metabolism reports · 2022
    Article
  7. Article
  8. Article
  9. DNA methylation impact on Fabry disease.Clinical epigenetics · 2021
    Review
  10. DNA Methylation Profiles ofBiomolecules · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Giulia De RisoDepartment of Molecular Medicine and Medical Biotechnology, Università degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131 Naples, Italy.
Mariella CuomoDepartment of Molecular Medicine and Medical Biotechnology, Università degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131 Naples, Italy.
Teodolinda Di RisiCEINGE Biotecnologie Avanzate, via Gaetano Salvatore 482, 80145 Naples, Italy.
Rosa Della MonicaCEINGE Biotecnologie Avanzate, via Gaetano Salvatore 482, 80145 Naples, Italy.
Michela BuonaiutoDepartment of Molecular Medicine and Medical Biotechnology, Università degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131 Naples, Italy.
Davide CostabileDepartment of Molecular Medicine and Medical Biotechnology, Università degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131 Naples, Italy.
Antonio PisaniDepartment of Sanità Pubblica, Università degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131 Naples, Italy.
Sergio CocozzaDepartment of Molecular Medicine and Medical Biotechnology, Università degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131 Naples, Italy.
Lorenzo ChiariottiDepartment of Molecular Medicine and Medical Biotechnology, Università degli Studi di Napoli 'Federico II', Via S. Pansini, 5, 80131 Naples, Italy.
University of Naples Federico II · ITCeinge Biotecnologie Avanzate (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recessive X-linked disorders may occasionally evolve in clinical manifestations of variable severity also in female carriers. For some of such diseases, the frequency of the symptoms' appearance during women's life may be particularly relevant. This phenomenon has been largely attributed to the potential skewness of the X-inactivation process leading to variable phenotypes. Nonetheless, in many cases, no correlation with X-inactivation unbalance was demonstrated. However, methods for analyzing skewness have been mainly limited to Human Androgen Receptor methylation analysis (HUMARA). Recently, the X-inactivation process has been largely revisited, highlighting the heterogeneity existing among loci in the epigenetic state within inactive and, possibly, active X-chromosomes. We reasoned that gene-specific and ultra-deep DNA methylation analyses could greatly help to unravel details of the X-inactivation process and the roles of specific X genes inactivation in disease manifestations. We recently provided evidence that studying DNA methylation at specific autosomic loci at a single-molecule resolution (epiallele distribution analysis) allows one to analyze cell-to-cell methylation differences in a given cell population. We here apply the epiallele analysis at two X-linked loci to investigate whether females show allele-specific epiallelic patterns. Due to the high potential of this approach, the method allows us to obtain clearly distinct allele-specific epiallele profiles.

Indexed as

Allelesalpha-GalactosidaseChromosomes, Human, XCpG IslandsDNA MethylationFemaleGenes, X-LinkedHeterozygoteHumansReceptors, AndrogenX Chromosome Inactivationalpha-GalactosidaseAR protein, humanGLA protein, humanReceptors, AndrogenDNA methylationepiallele analysisFabry diseaseskewness X-inactivationX-linked genes

Identifiers

PMID32512878
PMCPMC7349208
OpenAlexW3033860894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.